Introduction
“Shaking” is a general term often used by patients to describe involuntary, rhythmic, oscillatory movements of one or more body parts. In medical terminology, this is most often referred to as a tremor. Shaking can be a benign, physiological phenomenon (such as shivering from cold or nervousness) or a manifestation of significant neurological, metabolic, or systemic disease.
The most common causes include essential tremor, Parkinson’s disease, medication-induced tremor, hyperthyroidism, anxiety, alcohol withdrawal, and systemic disorders. Distinguishing between these requires careful evaluation, as management varies from reassurance to targeted pharmacological or surgical intervention.
Types of Tremors
-
Physiological Tremor: Normal, low-amplitude tremor seen in everyone; exaggerated by stress, caffeine, or fatigue.
-
Essential Tremor: The most common pathological tremor, typically postural or kinetic, often affecting both hands.
-
Parkinsonian Tremor: Resting tremor, “pill-rolling,” asymmetrical, decreases with movement.
-
Cerebellar Tremor: Intention tremor, worsens as the hand approaches a target; due to cerebellar lesions.
-
Holmes Tremor: Combination of rest, action, and postural tremors, usually from brainstem/midbrain lesions.
-
Drug- or Toxin-Induced Tremor: From stimulants, lithium, valproate, corticosteroids, alcohol withdrawal.
-
Psychogenic Tremor: Variable, inconsistent, often distractible.
Etiology of Shaking
1. Neurological Causes
-
Parkinson’s disease.
-
Essential tremor.
-
Cerebellar disorders (stroke, tumor, multiple sclerosis).
-
Peripheral neuropathy.
-
Dystonia.
2. Systemic and Metabolic Causes
-
Hyperthyroidism (thyrotoxic tremor).
-
Hypoglycemia.
-
Electrolyte disturbances (low calcium, magnesium, potassium).
-
Hepatic encephalopathy (asterixis or “flapping tremor”).
-
Uremic encephalopathy.
3. Medication- or Substance-Related
-
Drugs: lithium, valproate, SSRIs, beta-adrenergic agonists (salbutamol), corticosteroids, caffeine.
-
Alcohol withdrawal (tremulousness).
-
Stimulants (amphetamines, cocaine).
4. Psychiatric Causes
-
Anxiety disorders.
-
Panic attacks.
-
Psychogenic tremor.
5. Physiological Causes
-
Fatigue.
-
Emotional stress.
-
Cold exposure (shivering).
Clinical Presentation
-
Location: Hands, arms, head, voice, legs, trunk.
-
Timing: Resting (Parkinson’s) vs postural/action (essential tremor) vs intention (cerebellar).
-
Amplitude/frequency: Fine vs coarse.
-
Associated symptoms:
-
Rigidity, bradykinesia (Parkinson’s).
-
Gait instability (cerebellar).
-
Sweating, palpitations, anxiety (thyrotoxicosis, hypoglycemia).
-
Confusion, asterixis (hepatic/uremic encephalopathy).
-
Diagnostic Evaluation
1. History
-
Onset, progression, triggers, relieving factors.
-
Family history (essential tremor often inherited).
-
Alcohol response (improvement suggests essential tremor).
-
Medication and substance use.
2. Physical Examination
-
Tremor type: rest, postural, action, intention.
-
Neurological exam: rigidity, reflexes, coordination.
-
Thyroid exam: goiter, tachycardia.
-
Signs of systemic illness: jaundice, edema, confusion.
3. Laboratory Tests
-
Thyroid function tests (TSH, free T4).
-
Blood glucose (hypoglycemia).
-
Electrolytes, liver function, renal function.
-
Toxicology/drug screen if needed.
4. Imaging
-
Brain MRI: cerebellar lesions, stroke, tumors.
-
DaTscan (dopamine transporter imaging) in atypical Parkinson’s cases.
Management
Treatment is cause-specific, supplemented by general symptomatic therapy.
1. Essential Tremor
-
First-line pharmacological agents:
-
Propranolol 40–120 mg/day orally in divided doses (can increase to 320 mg/day if tolerated).
-
Primidone 25–50 mg orally at bedtime, gradually titrated to 250 mg twice daily.
-
-
Second-line therapies:
-
Topiramate 25–100 mg/day orally.
-
Gabapentin 300–1200 mg/day orally in divided doses.
-
-
Procedural therapies (refractory cases):
-
Botulinum toxin injections (for head/voice tremors).
-
Deep brain stimulation (DBS) of ventral intermediate nucleus of thalamus.
-
2. Parkinson’s Disease Tremor
-
Levodopa/carbidopa: Start 100/25 mg orally three times daily; titrate as needed.
-
Dopamine agonists:
-
Pramipexole 0.125–1.5 mg orally three times daily.
-
Ropinirole 0.25–8 mg orally three times daily.
-
-
Anticholinergics (younger patients only):
-
Trihexyphenidyl 1–2 mg orally two to three times daily (max 15 mg/day).
-
-
Amantadine: 100 mg orally twice daily.
3. Cerebellar Tremor
-
Often resistant to medications.
-
Supportive therapy: physiotherapy, occupational therapy.
-
Trial of Clonazepam 0.5–2 mg orally twice daily may reduce amplitude.
-
Surgical options (DBS, thalamotomy) in refractory cases.
4. Metabolic and Systemic Tremors
-
Thyrotoxicosis:
-
Propranolol 20–40 mg orally three to four times daily.
-
Methimazole 10–30 mg/day orally in divided doses.
-
-
Hypoglycemia-induced shaking:
-
Immediate oral glucose (15–20 g).
-
IV Dextrose 25–50 mL of 50% solution if unconscious.
-
Glucagon 1 mg intramuscular if IV access unavailable.
-
-
Hepatic encephalopathy (asterixis):
-
Lactulose 15–30 mL orally two to four times daily, titrated to 2–3 soft stools per day.
-
Rifaximin 550 mg orally twice daily.
-
-
Uremic encephalopathy:
-
Dialysis is definitive treatment.
-
5. Medication/Substance-Induced Tremor
-
Review and discontinue offending drugs if possible.
-
Benzodiazepines may be used short-term in withdrawal states:
-
Diazepam 5–10 mg orally every 8–12 hours as needed.
-
-
Alcohol withdrawal:
-
Chlordiazepoxide 25–50 mg orally every 6 hours, tapered over 5–7 days.
-
6. Psychogenic Tremor
-
Psychological support, reassurance, and cognitive behavioral therapy (CBT).
-
Short-term anxiolytics if severe anxiety: Lorazepam 0.5–2 mg orally as needed.
-
SSRIs (e.g., Sertraline 50–200 mg orally once daily) for long-term management.
Precautions and Patient Counseling
-
Emphasize lifestyle modifications: avoid caffeine, nicotine, stimulants.
-
Encourage alcohol moderation; rebound worsening occurs after withdrawal.
-
Stress adherence to prescribed medication regimens.
-
Educate on safety: using assistive devices if tremors impair daily activities.
-
Advise patients with Parkinson’s or severe essential tremor about surgical options if drug therapy fails.
Drug Interactions
-
Propranolol: Interacts with calcium channel blockers (risk of bradycardia, hypotension). May reduce hypoglycemic awareness in diabetics.
-
Primidone: Interacts with warfarin, oral contraceptives (induces CYP enzymes).
-
Topiramate: Reduces efficacy of oral contraceptives; additive sedation with alcohol, CNS depressants.
-
Levodopa/carbidopa: Reduced absorption with high-protein diet; interacts with MAO inhibitors (hypertensive crisis).
-
Trihexyphenidyl: Additive anticholinergic effects with antihistamines, tricyclic antidepressants.
-
Methimazole: May enhance anticoagulant effect of warfarin.
-
Lactulose: May alter absorption of other oral drugs due to GI motility changes.
-
Rifaximin: Interacts with cyclosporine (increases levels).
-
Benzodiazepines: Additive CNS depression with opioids, alcohol, sedatives.
-
SSRIs: Risk of serotonin syndrome with other serotonergic drugs (triptans, MAOIs).
Prognosis
-
Essential tremor: Chronic but benign; can be controlled with medications or surgery.
-
Parkinson’s disease tremor: Progressive; requires long-term dopaminergic therapy.
-
Cerebellar tremor: Often resistant to treatment but supportive therapy helps function.
-
Metabolic tremors: Reversible if underlying cause treated (thyrotoxicosis, hypoglycemia, hepatic encephalopathy).
-
Psychogenic tremors: Good prognosis with psychological intervention.
No comments:
Post a Comment